Modulation of human renal cell carcinoma 786-0 MMP-2 and MMP-9 activity by inhibitors and inducers in vitro

Medical Oncology

Volumn 23, Issue 2, 2006, Pages 245-250

  Roomi, M Waheed ^a   Ivanov, Vadim ^a   Kalinovsky, Tatiana ^a,b   Niedzwiecki, Aleksandra ^a   Rath, Matthias ^a  

^a Dr Rath Research Institute   (United States)

^b NONE   (United States)

Author keywords

Inhibitors, nutrient mixture; MMP 2 ; MMP 9, inducers; Renal cancer

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CYTOKINE; DACTINOMYCIN; DEXAMETHASONE; DOXYCYCLINE; EPIGALLOCATECHIN GALLATE; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MATRIGEL; PENICILLIN G; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; STREPTOMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN SECRETION; ZYMOGRAPHY;

ANTINEOPLASTIC AGENTS; CARCINOGENS; CARCINOMA; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-1; KIDNEY NEOPLASMS; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646874153     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:23:2:245     Document Type: Article

References (15)

1. Mancuso A, Sternberg CN. New treatments for metastatic kidney cancer. Can J Urol 2005; 12(1): 66-70.
2. Zhang Y, Wu XH, Cao GH, Li S. Relationship between expression of matrix metalloproteinase-9 (MMP-9) and angiogenesis in renal cell carcinoma. Ai Zheng 2004; 23(3): 326-329.
3. Cho NH, et al. Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma. Eur Urol 2003; 44(5): 560-566.
4. Johnson LL, Dyer R, Hupe DJ. Matrix metalloproteinases. Curr Opin Chem Biol 1998; 2: 466-471.
5. Rath M, Pauling L. Plasmin-induced proteolysis and the role of apoproteina, lysine and synthetic analogs. J Ortho Med 1992; 7: 17-23.
6. Roomi MW, et al. Antitumor effect of nutrient synergy on human osteosarcoma cells U2OS, MNNG-HOS, and Ewing's Sarcoma SK-ES.1. Oncol Rep 2005; 13(2): 253-257.
7. Roomi MW, et al. In Vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid and green tea extract on human breast cancer lines MDA MB-231 and MCF-7. Med Oncol 2005; 22(2): 129-138.
8. Roomi MW, et al. Synergistic effect of combination of lysine, proline, arginine, ascorbic acid, and epigallocatechin gallate on colon cancer cell line HCT 116. JANA 2004; 7(2): 40-43.
9. Roomi MW, et al. Antitumor effect of a combination of lysine, proline, arginine, ascorbic acid, and green tea extract on pancreatic cancer cell line MIA PaCa-2. Int J Gastrointest Cancer 2005; 35(2): 97-102.
10. Roomi MW et al. In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human colon cancer cell HCT 116 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry. Oncol Rep 2005; 13(3): 421-425.
11. Roomi MW, et al. In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human prostate cancer PC-3 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry. In Vivo 2005; 19(1): 179-183.
12. Roomi MW, et al. Modulation of N-methyl-N-nitrosourea-induced mammary tumors in Sprague-Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Research 2005; 7:R291-R295.
13. Benbow U, Brinckerhogg CE. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 1997; 15: 519-526.
14. O-Charoenrat P, et al. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. Cancer Res 2000; 60: 1121-1128.
15. Almholt K, et al. Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice. Int J Cancer 2005; 113(4): 525-532.